The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer
Open accessAbstract
Tumor cells rely on glutamine to fulfill their metabolic demands and sustain proliferation. The elevated consumption of glutamine can lead to intratumoral nutrient depletion, causing metabolic stress that has the potential to impact tumor progression. Here, we show that nutrient stress caused by glutamine deprivation leads to the induction of epithelial–mesenchymal transition (EMT) in pancreatic ductal adenocarcinoma (PDAC) cells. Mechanistically, we demonstrate that glutamine deficiency regulates EMT through the up-regulation of the EMT master regulator Slug, a process that is dependent on both MEK/ERK signaling and ATF4. We find that Slug is required in PDAC cells for glutamine deprivation–induced EMT, cell motility, and nutrient stress survival. Importantly, we decipher that Slug is associated with nutrient stress in PDAC tumors and is required for metastasis. These results delineate a novel role for Slug in the nutrient stress response and provide insight into how nutrient depletion might influence PDAC progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“extracellular asparagine from serum and produced by a constitutively active integrated stress response in subpopulations of PDAC cells can be targeted using asparaginase, potently sensitizing PDAC tumors to mitochondrial inhibition in pre-clinical models239,246.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [239]
In the citing paper
“Differential activation of the integrated stress response can also be used to define sub-populations within individual tumors, which drives differential sensitivity to metabolic inhibitors239.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [239]
In the citing paper
“metabolic characterization of clonal lines isolated from tumors revealed that two distinct populations can co-exist within the same tumor239”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [239]
In the citing paper
“asparagine produced by subpopulations of PDAC cells that have a constitutively active integrated stress response support the mitochondrial metabolism of other PDAC cells during limited respiration239, providing a barrier to metabolic targeting.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [239]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
The integrated stress response
Pakos‐Zebrucka, K., Koryga, I., Mnich, K., Ljujic, M., Samali, A., & Gorman, A. M. (2016) · The EMBO Reports · doi:10.15252/embr.201642195 · Cited by 2,659
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
Flagged first, then by citations
Cited by
Sorted by citations
Pancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321
Wang, Z., Liu, F., Fan, N., Zhou, C., Li, D., MacVicar, T., Dong, Q., Bruns, C. J., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.589508 · Cited by 189
Metabolic heterogeneity in cancer
Demicco, M., Liu, X., Leithner, K., & Fendt, S. (2024) · Nature Metabolism · doi:10.1038/s42255-023-00963-z · Cited by 186
Harnessing metabolic dependencies in pancreatic cancers
Encarnación-Rosado, J., & Kimmelman, A. C. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00431-7 · Cited by 190
The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression
Fedele, M., Sgarra, R., Battista, S., Cerchia, L., & Manfioletti, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020800 · Cited by 171
The epithelial–mesenchymal plasticity landscape: principles of design and mechanisms of regulation
Haerinck, J., Goossens, S., & Berx, G. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00601-0 · Cited by 142
Targeting pancreatic cancer metabolic dependencies through glutamine antagonism
Encarnación-Rosado, J., Sohn, A. S. W., Biancur, D. E., Lin, E. Y., Osorio-Vasquez, V., Rodrick, T. C., González-Baerga, D., Zhao, E., Yokoyama, Y., Simeone, D. M., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00647-3 · Cited by 138
Yu, D., Pan, M., Li, Y., Lu, T., Wang, Z., Liu, C., & Hu, G. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02212-1 · Cited by 123
Zhang, Y., Recouvreux, M. V., Jung, M., Galenkamp, K. M. O., Li, Y., Zagnitko, O., Scott, D. A., Lowy, A. M., & Commisso, C. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0119 · Cited by 116
Self-citationPlasticity of cancer invasion and energy metabolism
Parlani, M., Jorgez, C. J., & Friedl, P. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.09.009 · Cited by 106
Kuzu, O. F., Granerud, L. J. T., & Saatcioglu, F. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02439-w · Cited by 128
Zhu, Y.-H., Zheng, J.-H., Jia, Q.-Y., Duan, Z., Yao, H., Yang, J., Sun, Y., Jiang, S.-H., Liu, D., & Huo, Y. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00741-1 · Cited by 98
Obesity and Cancer Metastasis: Molecular and Translational Perspectives
Annett, S., Moore, G., & Robson, T. (2020) · Cancers · doi:10.3390/cancers12123798 · Cited by 93
Stress Granules Determine the Development of Obesity-Associated Pancreatic Cancer
Fonteneau, G., Redding, A., Hoag-Lee, H., Sim, E. S., Heinrich, S., Gaida, M. M., & Grabocka, E. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1672 · Cited by 86
Zhou, Q., Lin, W., Wang, C., Sun, F., Ju, S., Chen, Q., Wang, Y., Chen, Y., Li, H., Wang, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30559-2 · Cited by 80
Recouvreux, M. V., Grenier, S. F., Zhang, Y., Esparza, E., Lambies, G., Galapate, C. M., Maganti, S., Duong‐Polk, K., Bhullar, D., Naeem, R. F., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00649-1 · Cited by 79
Self-citationNazemi, M., Yanes, B., Llanses, M., Walker, H. J., Pham, K. T., Collins, M. O., Bard, F., & Rainero, E. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002406 · Cited by 67
Palamaris, K., Felekouras, E. S., & Sakellariou, S. (2021) · Cancers · doi:10.3390/cancers13215532 · Cited by 70
Metabolic reprogramming of immune cells in pancreatic cancer progression
Xiang, H., Yang, R., Tu, J., Yan, X., Yang, S., Lv, L., Zhai, X., Zhu, Y., Dong, D., & Tao, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113992 · Cited by 64
Ghafoor, S., Garcia, E. P., Jay, D. J., & Persad, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094364 · Cited by 71
Guo, Z., Ashrafizadeh, M., Zhang, W., Zou, R., Sethi, G., & Zhang, X. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10125-y · Cited by 63
Jain, A., & Bhardwaj, V. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i39.6527 · Cited by 64
Metabolic dependencies and targets in ovarian cancer
Zhang, Y., Wang, Y., Zhao, G., Oršulić, S., & Matei, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108413 · Cited by 65
Self-citationYang, L.-X., Qi, C., Lu, S., Ye, X.-S., Merikhian, P., Zhang, D.-Y., Yao, T., Zhao, J.-S., Wu, Y., Jia, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55738-1 · Cited by 57
Yang, J. Z., Liu, Y., & Liu, S. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06032-3 · Cited by 61
Shu, F., Liu, H., Chen, X., Liu, Y., Zhou, J., Tang, L., Cao, W., Yang, S., Long, Y., Li, R., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1954 · Cited by 56
Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer
Zhang, Y., Li, L., Murad, R., Maganti, S., Manceau, A., Faso, H. A., Neff, M., Galapate, C. M., Grenier, S. F., Carrette, F., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.06.021 · Cited by 57
Self-citationTargeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment
Yamamoto, K., Iwadate, D., Kato, H., Nakai, Y., Tateishi, K., & Fujishiro, M. (2022) · Cancers · doi:10.3390/cancers14184351 · Cited by 52
Hua, Q., Sun, Z., Liu, Y., Shen, X., Zhao, W., Zhu, X., & Xu, P. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04149-x · Cited by 45
Zhao, R., Yi, Y., Liu, H., Xu, J., Chen, S., Wu, D., Wang, L., & Li, F. (2024) · Cancer & Metabolism · doi:10.1186/s40170-024-00362-2 · Cited by 48
Mirzaei, S., Abadi, A. J., Gholami, M. H., Hashemi, F., Zabolian, A., Hushmandi, K., Zarrabi, A., Entezari, M., Aref, A. R., Khan, H. Z., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174344 · Cited by 44
PAK4 in cancer development: Emerging player and therapeutic opportunities
Yuan, Y., Zhang, H., Li, D., Li, Y., Lin, F., Wang, Y., Song, H., Liu, X., Li, F., & Zhang, J. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215813 · Cited by 44
Therapeutic potential of NR4A1 in cancer: Focus on metabolism
Deng, S., Chen, B., Huo, J., & Liu, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.972984 · Cited by 46
Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma
Saggese, P., Pandey, A., Alcaraz, M., Fung, E., Hall, A., Yanagawa, J., Rodriguez, E. F., Grogan, T., Giurato, G., Nassa, G., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1148 · Cited by 44
Masuo, K., Chen, R., Yogo, A., Sugiyama, A., Fukuda, A., Masui, T., Üemoto, S., Seno, H., & Takaishi, S. (2021) · Cancer Science · doi:10.1111/cas.15162 · Cited by 41
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
Erice, O., Narayanan, S., Feliu, I., Entrialgo‐Cadierno, R., Malinova, A., Vicentini, C., Guruceaga, E., Delfino, P., Trajkovic‐Arsic, M., Moreno, H., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0794 · Cited by 41
Liang, X., Yan, Z., Wang, P., Liu, Y., Ao, X., Liu, Z., Wang, D., Liu, X., Zhu, M., Gao, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111309 · Cited by 39
Fang, Z., Zhang, W., Wang, H., Zhang, C., Li, J., Chen, W., Xu, X., Wang, L., Ma, M., Zhang, S., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05491-x · Cited by 39
Sun, H., Zhang, C., Yang, Z., Liu, C., Wang, X., & Cong, X. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03523-3 · Cited by 38
Microfluidic System to Analyze the Effects of Interleukin 6 on Lymphatic Breast Cancer Metastasis
Cho, H., Choi, J., Kim, K.-J., Shin, M., & Choi, J. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.611802 · Cited by 37
Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy
Zarrabi, A., Bishayee, A., Mirzaei, S., Gholami, M. H., Zabolian, A., Saleki, H., Bagherian, M., Torabi, S. M., Sharifzadeh, S. O., Hushmandi, K., et al. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220415131344 · Cited by 34
Xing, Y., & Liu, C. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02683-7 · Cited by 32
Chisari, A. N., Golán, I., Campisano, S., Gélabert, C., Moustakas, A., Sancho, P., & Caja, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.723798 · Cited by 33
Pastorino, G. A., Sheraj, I., Huebner, K., Ferrero, G., Kunze, P., Hartmann, A., Hampel, C., Hüsnügil, H. H., Maiuthed, A., Gebhart, F., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6240 · Cited by 31
Shi, L., Hou, J., Wang, L., Fu, H., Zhang, Y., Song, Y., & Wang, X. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.486 · Cited by 28
Self-citationLan, B., Zhuang, Z., Zhang, J., He, Y., Wang, N., Deng, Z., Mei, L., Li, Y., & Gao, Y. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06936-8 · Cited by 27
van Roey, R., Brabletz, T., Stemmler, M. P., & Armstark, I. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.753456 · Cited by 26
Bandi, D. S. R., Sarvesh, S., Farran, B., Nagaraju, G. P., & El‐Rayes, B. F. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.06.006 · Cited by 26
The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment
Li, Y., Zhang, J., Xu, J., & Liu, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.759376 · Cited by 24
Peng, X., Yang, R., Song, J. L., Wang, X., & Dong, W. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.783592 · Cited by 24
Jiang, Z., Song, X., Wei, Y., Li, Y., Kong, D., & Sun, J. (2022) · Bioengineered · doi:10.1080/21655979.2022.2088497 · Cited by 24
RetractedGuo, H., Hu, Z., Yang, X., Yuan, Z., Gao, Y., Chen, J., Xie, L., Chen, C., Guo, Y., & Bai, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110709 · Cited by 25
Dou, R., Han, L., Yang, C., Fang, Y., Zheng, J., Liang, C., Song, J., Chen, W., Huang, G., Zhong, P., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1432 · Cited by 24
Wu, H., Zhang, Q., Cao, Z., Cao, H., Wu, M., Fu, M., Huang, T., Han, X., Chang, X., & Liu, Z. (2025) · iScience · doi:10.1016/j.isci.2025.112681 · Cited by 22
Wu, S., Sun, Z., Guo, Z., Li, P., Mao, Q., Tang, Y., Chen, H., Peng, H., Wang, S., & Cao, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116565 · Cited by 25
Yuan, H., Zhao, Z., Guo, Z., Ma, L., Han, J., & Song, Y. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72838 · Cited by 22
RNA-cleaving DNAzymes for accurate biosensing and gene therapy
Gao, X., Liu, Y., Huo, W., Song, Y., Chen, Y., Zhang, J., Yang, X., Jin, Y., & Liang, X. (2023) · Nanoscale · doi:10.1039/d3nr01482g · Cited by 22
Wang, X., Zhou, L., Wang, H., Chen, W., Jiang, L., Ming, G., & Wang, J. (2023) · Cancer Medicine · doi:10.1002/cam4.6623 · Cited by 21
Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression
Ogunleye, A. O., Nimmakayala, R. K., Batra, S. K., & Ponnusamy, M. P. (2023) · Stem Cells · doi:10.1093/stmcls/sxad017 · Cited by 21
Gao, C., Chu, Z.-Z., Zhang, D., Xiao, Y., Zhou, X.-Y., Wu, J., Yuan, H., Jiang, Y., Chen, D., Zhang, J., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02651-4 · Cited by 21
Archibugi, L., Ruta, V., Panzeri, V., Redegalli, M., Testoni, S. G. G., Petrone, M. C., Rossi, G., Falconi, M., Reni, M., Doglioni, C., et al. (2020) · Cells · doi:10.3390/cells9122561 · Cited by 20
The biology of pancreatic cancer morphology
McDonald, O. G. (2021) · Pathology · doi:10.1016/j.pathol.2021.09.012 · Cited by 20
Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment
He, S., Zhang, S., Yao, Y., Xu, B., Niu, Z., Liao, F., Wu, J., Song, Q., Li, M., & Liu, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1064127 · Cited by 17
Lv, Q., Shi, J., Miao, D., Tan, D., Zhao, C., Xiong, Z., & Zhang, X. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101835 · Cited by 18
What’s on the menu?: metabolic constraints in the pancreatic tumor microenvironment
Sheehan, C. S., & Muir, A. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191940 · Cited by 19
The role of amino acid metabolism alterations in pancreatic cancer: From mechanism to application
Fu, S., Xu, S., & Zhang, S. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188893 · Cited by 18
Zhuo, W., Zeng, Z., Hu, Y., Hu, P., Han, S., Wang, D., Wang, F., Zhao, Y., Huang, Y., Wang, J., et al. (2023) · Cancer Science · doi:10.1111/cas.15905 · Cited by 17
Giraulo, C., Turiello, R., Orlando, L., Leonardelli, S., Landsberg, J., Belvedere, R., Rolshoven, G. W., Müller, C. E., Hölzel, M., & Morello, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115225 · Cited by 17
Wu, C., Weis, S. M., & Cheresh, D. A. (2023) · Journal of Cell Science · doi:10.1242/jcs.261483 · Cited by 18
MicroRNA-Regulated Signaling Pathways: Potential Biomarkers for Pancreatic Ductal Adenocarcinoma
Mortoglou, M., Wallace, D., Djordjević, A. B., Djordjevic, V. R., Arısan, E. D., & Onganer, P. U. (2021) · Stresses · doi:10.3390/stresses1010004 · Cited by 17
Fang, J., Wang, J., Yu, L., & Xu, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.684021 · Cited by 17
TANG, F., LI, Y., Pan, M., WANG, Z., Lu, T., Liu, C., Zhou, X. Y., & Hu, G. (2023) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.030081 · Cited by 16
Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
Hua, Q., Li, T., Liu, Y., Shen, X., Zhu, X., & Xu, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.624837 · Cited by 16
Yang, J., Xu, Y. H., Huo, Y., Cai, L., Hua, R., Zhang, J., & Chen, Z. (2021) · Journal of Immunology Research · doi:10.1155/2021/5553425 · Cited by 15
Shi, J., Li, W., Jia, Z., Peng, Y., Hou, J., Li, N., Meng, R., Fu, W., Feng, Y., Wu, L., et al. (2023) · Cancers · doi:10.3390/cancers15215282 · Cited by 15
Zeng, T., Deng, T., Liu, Z., Zhan, J., Ma, Y., Yan, Y.-Y., Sun, X., Zhu, Y., Li, Y., Guan, X., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05478-1 · Cited by 15
Sun, J., Zhao, X., Jiang, H., Yang, T., Li, D., Yang, X., Jia, A., Ma, Y., & Qian, Z. (2022) · Tissue and Cell · doi:10.1016/j.tice.2022.101817 · Cited by 14
Huang, Y., Chen, Y., Zhou, S., Xie, L., Liang, K., Xu, J., Zhang, Q., Chen, H., Wang, D., Song, Q., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c04069 · Cited by 13
Zhang, H., Xu, W., Zhu, H., Chen, X., & Tsai, H. (2024) · Journal of Cancer · doi:10.7150/jca.92502 · Cited by 13
Gu, M., Liu, Y., Xin, P., Guo, W., Zhao, Z., Xu, Y., Ma, R., Jiao, T., & Zheng, W. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216738 · Cited by 13
Hou, T., Zhang, J., Wang, Y., Zhang, G., Li, S., Fan, W., Li, R., Sun, Q., & Liu, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052992 · Cited by 13
Anti‐Tumor Strategies Targeting Nutritional Deprivation: Challenges and Opportunities
Shi, J., Han, W., Wang, J., & Kong, X. (2025) · Advanced Materials · doi:10.1002/adma.202415550 · Cited by 14
Li, H., Wu, Z., Zhang, Y., Lu, X., & Miao, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1201297 · Cited by 13
Self-citationMechanism and function of miR-140 in human cancers: A review and in silico study
Taheri, F., Ebrahimi, S. O., Heidari, R., pour, S. N., & Reiisi, S. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154265 · Cited by 12
Nayak, D., Weadick, B., Persaud, A. K., Raj, R., Shakya, R., Li, J., Campbell, M. J., & Govindarajan, R. (2022) · iScience · doi:10.1016/j.isci.2022.104193 · Cited by 11
Greco, L., Rubbino, F., & Laghi, L. (2022) · Cancers · doi:10.3390/cancers14235797 · Cited by 13
Lin, J., Hou, L., Zhao, X., Zhong, J., Lv, Y., Jiang, X., Ye, B., & Qiao, Y. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.04.025 · Cited by 10
Squalli, W., Mansouri, I., Douini, I., Achiban, H., Saghrouchni, H., Agy, A. E., Fadil, F., Wink, M., & Dakki, M. (2024) · Animals · doi:10.3390/ani14091352 · Cited by 10
Hashimoto, A., & Hashimoto, S. (2024) · Cancers · doi:10.3390/cancers16234094 · Cited by 11
Glutamine’s double-edged sword: fueling tumor growth and offering therapeutic hope
Fang, L., Gao, D., Jiang, Z., Li, G., & Li, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1578940 · Cited by 9
Zhong, Y., Lu, Y., Li, J., Ren, Q., Fan, Y., Meng, X., Shao, J., & Qian, H. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02682 · Cited by 10
Hashimoto, A., Handa, H., Hata, S., & Hashimoto, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005566 · Cited by 9
Wang, X., Kutschat, A. P., Aggrey-Fynn, J. E., Hamdan, F. H., Graham, R. P., Wixom, A. Q., Souto, Y., Ladigan‐Badura, S., Yonkus, J. A., Abdelrahman, A. M., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0916 · Cited by 8
TRIM 2 promotes metabolic adaptation to glutamine deprivation via enhancement of CPT 1 A activity
Liao, K., Liu, K., Wang, Z., Zhao, K., & Mei, Y. (2024) · FEBS Journal · doi:10.1111/febs.17218 · Cited by 9
Yang, R., Ma, M., Yu, S., Li, X., Zhang, J., & Wu, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.742017 · Cited by 9
Wang, Z., He, T., Lv, W., & Hu, J. (2023) · Translational Cancer Research · doi:10.21037/tcr-22-2200 · Cited by 9
Melanophilin-induced primary cilia promote pancreatic cancer metastasis
Chao, Y.-Y., Lin, R.-C., Su, P.-J., Wang, C.-A., Tu, T.-Y., Hou, Y.-C., Tsai, Y., Peng, I.-C., Tsai, S.-J., Shan, Y., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07344-2 · Cited by 11
Parejo-Alonso, B., Barneda, D., Trabulo, S. M. D., Courtois, S., Compte-Sancerni, S., Zurkovic, J., Ruíz-Cañas, L., Zheng, Q., Tang, J., Gaida, M. M., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3475 · Cited by 8
Bacteria and tumor debris induced pancreatic cancer progression via the NF-κB signaling pathway
Chen, Q., Xu, Y., Wang, Y., Zheng, S., Yao, T., Qiu, J., Qin, H., & Liang, T. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217964 · Cited by 8
Yu, Y., Wang, Y., Zou, Y., & Yu, Y. (2022) · Disease Markers · doi:10.1155/2022/5286820 · Cited by 8
Metadata
- Authors
- Recouvreux, M. V., Moldenhauer, M. R., Galenkamp, K. M. O., Jung, M., James, B., Zhang, Y., Lowy, A., Bagchi, A., & Commisso, C.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- University of California San Diego (US)
- Corresponding author
- Commisso, Cosimo
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2020-06-08
- Volume
- 217
- Issue
- 9
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC7478719
- OpenAlex
- W3032930460
- Cited by
- 181
- References
- 57
- Citations by year
- 2026: 15 · 2025: 33 · 2024: 28 · 2023: 37 · 2022: 40 · 2021: 23 · 2020: 4
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01CA207189)
- National Cancer Institute (P30CA030199)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- glutamine deprivation, Slug, epithelial-mesenchymal transition, pancreatic ductal adenocarcinoma, nutritional stress, metabolic stress, MEK/ERK signaling, ATF4, metastasis, cell motility, tumor progression
- MeSH terms
- Snail Family Transcription Factors, Adenocarcinoma, Animals, Cell Movement, Cell Survival, Glutamine, Humans, Mice, Inbred C57BL, Neoplasm Metastasis, Pancreatic Neoplasms, RNA, Messenger, Stress, Physiological, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, MAP Kinase Signaling System, Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Activating Transcription Factor 4, HEK293 Cells, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review